IP Library › Granted Patent US 12,589,154
Granted Patent B2
US 12,589,154 · App. 17/618,358 · Granted Mar 31, 2026

Acid type sophorolipid-containing composition which is suppressed in browning

Inventors: Michiaki Araki (Kashiwara, JP); Yoshihiko Hirata (Kashiwara, JP)
Assignee: SARAYA CO., LTD.
A61K47/46A23L33/14A61K8/9728A61Q19/00C11D1/36A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,589,154
App. No.
17/618,358
Granted
Mar 31, 2026
Kind
B2
Abstract

The present invention provides an acidic sophorolipid-containing composition with suppressed browning and a method for producing the composition. The acidic sophorolipid-containing composition with suppressed browning according to the present invention is characterized in that a filtrate of a hydrolysate of a composition containing lactonic sophorolipid and acidic sophorolipid, i.e., a filtrate of the acidic sophorolipid-containing composition, has at least one of the following features (1) and (2): (1) hue value (Abs. 440): 5 or less; and (2) ethanol-insoluble content: less than 3 mass %.

Claims (20)

1 . A hydrolysate of a composition containing lactonic sophorolipid and acidic sophorolipid, the acidic sophorolipid being present in a proportion of 78 mass % or more, based on the total amount of the lactonic sophorolipid and the acidic sophorolipid taken as 100 mass %,

wherein a filtrate of the hydrolysate has the following features (1), (2), (4), (5), and (6):

(1) a hue value of 5 or less,

(2) an ethanol-insoluble content of less than 3 mass %,

(4) a pH of 6 to 9,

(5) a saponification value of 1 to 25 mgKOH/g, and

(6) an ignition residue content of 1.3 to 16 mass %,

wherein the filtrate of the hydrolysate is a filtrate obtained by adjusting the hydrolysate of the composition containing lactonic sophorolipid and acidic sophorolipid to room temperature 25±5° C. and then filtering the adjusted hydrolysate through a filter with a pore size of 0.45 μm, and

wherein the hue value is a value obtained by dissolving the filtrate in distilled water to achieve an ethanol-soluble content of 3 mass %, filtering the diluted aqueous solution through a filter with a pore size of 0.45 μm, measuring the absorbance of the obtained filtrate at a wavelength of 440 nm using an infrared/UV-visible spectrophotometer, and multiplying the absorbance by 10;

with the proviso that the hydrolysate excludes an acidic sophorolipid-composition obtained by hydrolyzing the composition containing lactonic sophorolipid and acidic sophorolipid and then purifying the resulting hydrolysate by column chromatography.

2 . The hydrolysate according to claim 1 , wherein the filtrate of the hydrolysate further has the following feature (3):

(3) a hue value after being allowed to stand at 50° C. in the dark for 1 month of 10 or less.

3 . A method for producing the hydrolysate of claim 1 , the method comprising the following steps (a) and (b):

(a) hydrolyzing a composition containing lactonic sophorolipid and acidic sophorolipid under conditions of 80° C. or less using an alkaline agent in an amount of 0.8 to 1.5 g eq. relative to the saponification value of the composition and

(b) adjusting the pH of the hydrolyzed composition of step (a) to a pH of 6 to 9 to obtain the hydrolysate.

4 . An anionic surfactant comprising the hydrolysate of claim 1 or a processed product thereof as an active ingredient.

5 . A perfumery or cosmetic, a food or drink, a detergent, a quasi-drug, a pharmaceutical, or an additive therefor, comprising the hydrolysate of claim 1 , or a processed product thereof.

6 . A method for producing the perfumery or cosmetic, the food or drink, the detergent, the quasi-drug, or the pharmaceutical of claim 5 , the method comprising the steps of mixing a third component for use in the manufacture of perfumery and cosmetics, foods and drinks, detergents, quasi-drugs, or pharmaceuticals into the hydrolysate or a processed product thereof; and forming the resulting mixture into a product.

7 . The production method according to claim 3 , wherein the filtrate of the hydrolysate further has the following feature (3):

(3) a hue value after being allowed to stand at 50° C. in the dark for 1 month of 10 or less.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2021
From: ARAKI, MICHIAKI; HIRATA, YOSHIHIKO
To: SARAYA CO., LTD.
Reel/Frame 058365/0662 →
Priority Claims (1)
JP 2019-108707 · Jun 11, 2019 · national
Continuity (1)
Related Publication 20220257773A1 · Aug 18, 2022
References Cited (113)
US 5417879A · Hall et al. · 1995 [cited by applicant]
US 5688930A · Bertho et al. · 1997 [cited by applicant]
US 5756471A · Hillion et al. · 1998 [cited by applicant]
US 5981497A · Maingault · 1999 [cited by applicant]
US 6057302A · Borzeix · 2000 [cited by applicant]
US 10065982B2 · Hirata et al. · 2018 [cited by applicant]
US 10688031B2 · Ito et al. · 2020 [cited by applicant]
US 10752650B2 · Araki et al. · 2020 [cited by applicant]
US 11312928B2 · Okada et al. · 2022 [cited by applicant]
US 20040171512A1 · Furuta et al. · 2004 [cited by applicant]
US 20110237531A1 · Yanagisawa et al. · 2011 [cited by applicant]
US 20120142621A1 · Falus et al. · 2012 [cited by applicant]
US 20120220464A1 · Giessler-Blank et al. · 2012 [cited by applicant]
US 20130035403A1 · Schaffer et al. · 2013 [cited by applicant]
US 20140349902A1 · Allef et al. · 2014 [cited by applicant]
US 20150056658A1 · Schaffer et al. · 2015 [cited by applicant]
US 20150056659A1 · Schaffer et al. · 2015 [cited by applicant]
US 20150056660A1 · Schaffer et al. · 2015 [cited by applicant]
US 20150056661A1 · Schaffer et al. · 2015 [cited by applicant]
US 20150112049A1 · Hirata et al. · 2015 [cited by applicant]
US 20150203443A1 · Klostermann et al. · 2015 [cited by applicant]
US 20150336999A1 · Jourdier et al. · 2015 [cited by applicant]
US 20160280733A1 · Araki et al. · 2016 [cited by applicant]
US 20160324747A1 · Ito et al. · 2016 [cited by applicant]
US 20180256489A1 · Silberstein et al. · 2018 [cited by applicant]
US 20200032168A1 · Okada et al. · 2020 [cited by applicant]
CN 102492753A · 2012 [cited by applicant]
CN 102695796A · 2012 [cited by applicant]
CN 104968325A · 2015 [cited by applicant]
CN 105593370A · 2016 [cited by applicant]
CN 105661630A · 2016 [cited by applicant]
CN 106282264A · 2017 [cited by applicant]
EP 0499434A1 · 1992 [cited by applicant]
EP 2351847A1 · 2011 [cited by applicant]
JP S56022399A · 1981 [cited by applicant]
JP H04170499A · 1992 [cited by applicant]
JP H05059394A · 1993 [cited by applicant]
JP H07118284A · 1995 [cited by applicant]
JP H10501260A · 1998 [cited by applicant]
JP H11508549A · 1999 [cited by applicant]
JP 2002045195A · 2002 [cited by applicant]
JP 2003009896A · 2003 [cited by applicant]
JP 2003013093A · 2003 [cited by applicant]
JP 2006070231A · 2006 [cited by applicant]
JP 2006083238A · 2006 [cited by applicant]
JP 2006212086A · 2006 [cited by applicant]
JP 2008247845A · 2008 [cited by applicant]
JP 2009062288A · 2009 [cited by applicant]
JP 2009531310A · 2009 [cited by applicant]
JP 2009275145A · 2009 [cited by applicant]
JP 2013511266A · 2013 [cited by applicant]
JP 2014117240A · 2014 [cited by applicant]
JP 2014150774A · 2014 [cited by applicant]
JP 2015100290A · 2015 [cited by applicant]
JP 2016000017A · 2016 [cited by applicant]
JP 2016160244A · 2016 [cited by applicant]
JP 6157524B2 · 2017 [cited by applicant]
WO WO2007130738A1 · 2007 [cited by applicant]
WO WO2010050413A1 · 2010 [cited by applicant]
WO WO2011061032A1 · 2011 [cited by applicant]
WO WO2011127101A1 · 2011 [cited by applicant]
WO WO2013129667A1 · 2013 [cited by applicant]
WO WO2015034007A1 · 2015 [cited by applicant]
Ashby et al., “Property control of sophorolipids: influence of fatty acid substrate and blending,” [cited by applicant]
Cooper et al., “Production of a Biosurfactant from Torulopsis bombicola,” [cited by applicant]
Gorin et al., “Hydroxy Fatty Acid Glycosides of Sophorose from Torulopsis Magnoliae,” [cited by applicant]
Japanese Patent Office, International Search Report in International Patent Application No. PCT/JP2020/001088 (Mar. 10, 2020). [cited by applicant]
Health Science Research Group, “Use Alternative Methods to Improve the Eye Irritation of Cosmetic Ingredients,” Workshop on OECD Guidelines for Testing of Chemicals, Guidelines for Evaluation (1998). [cited by applicant]
Asmer et al., “Microbial production , structure elucidation and bioconversion of sophorose lipids,” [cited by applicant]
Brakemeier et al., [cited by applicant]
Cavalero et al., “The effect of medium composition on the structure and physical state of sophorolipids produced by [cited by applicant]
Daniel et al., “Sophorolipid Production with High Yields on Whey Concentrate and Rapeseed Oil without Consumption of Lactose,” [cited by applicant]
Daverey, “Production, Characterization, and Properties of Sophorolipids from the Yeast [cited by applicant]
Davila et al., “Kinetics and balance of a fermentation free from product inhibition: sophorose lipid production by [cited by applicant]
Davila et al., “Identification and determination of individual sophorolipids in fermentation products by gradient elution high performance liquid chromatography with evaporative light-scattering detection,” [cited by applicant]
Deshpande et al., “Evaluation of sophorolipid biosurfactant production by [cited by applicant]
Gu et al., “A Study of the Scale-Up of Reversed-Phase Liquid Chromatography,” [cited by applicant]
Hirata et al., “Natural synergism of acid and lac tone type mixed sophorolipids in interfacial activities and cytotoxicities,” [cited by applicant]
Hommel, “Formation and physiological role of biosurfactants produced by hydrocarbon-utilizing microorganisms. Biosurfactants in hydrocarbon utilization,” [cited by applicant]
Liu et al., “Progress on biosynthesis and application of sophorolipids,” [cited by applicant]
Ma et al., “Effects of nitrogen sources on production and composition of sophorolipids by [cited by applicant]
Nuñez et al., “LC/MS analysis and lipase modification of the sophorolipids produced by Rhodotorula bogoriensis,” [cited by applicant]
Okamoto, “Recent developments of Draize eye test alternative in Japan,” [cited by applicant]
Rau et al., “Sophorolipids: a source for novel compounds,” [cited by applicant]
Saerens et al., “One-step production of unacetylated sophorolipids by an acetyltransferase negative [cited by applicant]
Shah et al., “Sophorolipids, microbial glycolipids with anti-human immunodeficiency virus and sperm-immobilizing activities,” [cited by applicant]
Shah et al., “Utilization of Restaurant Waste Oil as a Precursor for Sophorolipid Production,” [cited by applicant]
Song et al., “Structure characterization and physi-chemical properties of sophorolipid biosurfactants,” [cited by applicant]
Tulloch et al., “A new hydroxy fatty acid sophoroside from [cited by applicant]
Tulloch et al., “Structure and reactions of lactonic and acidic sophorosides of 17-hydroxyoctadecanoic acid,” [cited by applicant]
Van Bogaert et al. “Microbial production and application of sophorolipids,” [cited by applicant]
Yatim, “Biotransformation of Palm Olein into Sophorolipid Biosurfactant,” Doctor of Philosophy Thesis, University of New South Wales (2008). [cited by applicant]
Zhou et al., “Production of sophorose lipids by Torulopsis bombicola from safflower oil and glucose,” [cited by applicant]
Zhou et al., “Supramolecular Assemblies of a Naturally Derived Sophorolipid,” [cited by applicant]
China National Intellectual Property Administration, Office Action in Chinese Patent Application No. 201480054091.5 (Oct. 29, 2018). [cited by applicant]
China National Intellectual Property Administration, First Office Action in Chinese Patent Application No. 201880016429.6 (Oct. 19, 2020). [cited by applicant]
European Patent Office, Extended European Search Report in European Patent Application No. 14843085.3 (Feb. 23, 2017). [cited by applicant]
European Patent Office, Extended European Search Report in European Patent Application No. 14834955.8 (Nov. 16, 2016). [cited by applicant]
European Patent Office, Communication Pursuant to Article 94(3) EPC in European Patent Application No. 14834955.8 (Jul. 21, 2017). [cited by applicant]
European Patent Office, Third Party Observations for European Patent Application No. 14834955.8 (Jun. 19, 2020). [cited by applicant]
European Patent Office, Communication Pursuant to Rule 114(2) EPC in European Patent Application No. 14834955.8 (Jun. 19, 2020). [cited by applicant]
Japanese Patent Office, International Search Report in International Patent Application No. PCT/JP2014/070788 (Nov. 11, 2014). [cited by applicant]
Japanese Patent Office, Written Opinion of the International Searching Authority in International Patent Application No. PCT/JP2014/070788 (Nov. 11, 2014). [cited by applicant]
Japanese Patent Office, International Search Report in International Patent Application No. PCT/JP2014/073356 (Dec. 2, 2014). [cited by applicant]
Japanese Patent Office, Written Opinion of the International Searching Authority in International Patent Application No. PCT/JP2014/073356 (Dec. 2, 2014). [cited by applicant]
Japanese Patent Office, International Search Report in International Patent Application No. PCT/JP2018/008865 (Apr. 3, 2018). [cited by applicant]
Japanese Patent Office, Notice of Reasons for Refusal in Japanese Patent Application No. 2018-568976 (Jan. 22, 2019). [cited by applicant]
Baccile et al., “Practical Methods to Reduce Impurities for Gram-Scale Amounts of Acidic Sophorolipid Biosurfactants,” [cited by applicant]
European Patent Office, Extended European Search Report in European Patent Application No. 20822640.7 (Jun. 9, 2023). [cited by applicant]
U.S. Appl. No. 14/382,480, filed Sep. 2, 2014. [cited by applicant]
U.S. Appl. No. 14/911,174, filed May 23, 2016. [cited by applicant]
U.S. Appl. No. 15/061,330, filed Mar. 4, 2016. [cited by applicant]
U.S. Appl. No. 16/491,511, filed Sep. 5, 2019. [cited by applicant]